Compare YSS & STVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | YSS | STVN |
|---|---|---|
| Founded | 2012 | 1949 |
| Country | United States | Italy |
| Employees | 710 | N/A |
| Industry | Military/Government/Technical | Containers/Packaging |
| Sector | Industrials | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.2B | 3.7B |
| IPO Year | N/A | 2021 |
| Metric | YSS | STVN |
|---|---|---|
| Price | $32.14 | $18.12 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 3 |
| Target Price | ★ $36.56 | $25.67 |
| AVG Volume (30 Days) | ★ 2.5M | 566.8K |
| Earning Date | 03-19-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 0.39% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $48.43 | $9.67 |
| Revenue Next Year | $52.83 | $9.99 |
| P/E Ratio | ★ N/A | $27.15 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $16.93 | $12.89 |
| 52 Week High | $44.54 | $28.00 |
| Indicator | YSS | STVN |
|---|---|---|
| Relative Strength Index (RSI) | 51.66 | 77.75 |
| Support Level | $18.62 | $13.58 |
| Resistance Level | $44.54 | $26.94 |
| Average True Range (ATR) | 4.12 | 0.80 |
| MACD | -0.84 | 0.31 |
| Stochastic Oscillator | 25.37 | 93.16 |
York Space Systems Inc is a U.S.-based space and defense company that provides mission-related solutions for national security, government, and commercial customers. The company develops its own hardware and software, offering capabilities intended to support customer requirements across various elements of the space mission lifecycle. It offers mission solutions across several complementary product categories: Components, Subsystems, Spacecraft Platforms, Ground Operation, Global Downlink, and Software-Enabled Services. The company derives the majority of revenue from long-term firm-fixed-price (FFP) production contracts for the design of small satellites, launch services, and ground services with both U.S. federal government-controlled agencies and domestic commercial customers.
Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, It derives its majority revenue from Europe, Middle East and Africa.